{
    "clinical_study": {
        "@rank": "105722", 
        "acronym": "SOLECT", 
        "arm_group": [
            {
                "arm_group_label": "Treatment on Day 0", 
                "arm_group_type": "Experimental", 
                "description": "Subjects who are treated with the Solace Bladder Control System upon entry into the trial."
            }, 
            {
                "arm_group_label": "Sham Treatment on Day 0", 
                "arm_group_type": "Sham Comparator", 
                "description": "Patients who undergo a sham procedure upon entry into the trial, with treatment with the Solace Bladder Control System at 3 months after the sham procedure."
            }
        ], 
        "brief_summary": {
            "textblock": "The Solace European Confirmatory (SOLECT) Trial is designed to determine whether the Solace\n      Bladder Control System is safe and effective for the treatment of Stress Urinary\n      Incontinence (SUI) in adult females."
        }, 
        "brief_title": "Solace European Confirmatory Trial", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Stress Urinary Incontinence", 
        "condition_browse": {
            "mesh_term": [
                "Urinary Incontinence", 
                "Urinary Incontinence, Stress"
            ]
        }, 
        "detailed_description": {
            "textblock": "Subject will undergo treatment with the Solace Bladder Control System or a sham procedure,\n      with the results being compared at 3 months.\n\n      All patients undergoing sham treatment are treated at 3 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female 18 years of age or older with stress urinary incontinence (SUI)\n\n          -  Experienced SUI for at least 12 months and attempted and failed prior noninvasive\n             treatment\n\n          -  Willing to undergo cystoscopic procedures required and 36 month follow-up\n\n          -  On stable medication for a minimum of 3 months\n\n          -  Free of local genital skin infection\n\n          -  Positive Pad Weight Test\n\n          -  Free of impassable urethral strictures, trauma or necrosis\n\n        Exclusion Criteria (must answer NO):\n\n          -  Pregnant or planning to become pregnant during the study period\n\n          -  Non-ambulatory or bedridden or physically unable to complete test exercises\n\n          -  Morbidly obese (defined as BMI \u2265 40 kg/m2)\n\n          -  Bladder infection (including bladder inflammation or edema) or UTI within 3 months\n\n          -  History of recurrent urinary tract infections\n\n          -  Prior surgical procedure for incontinence within the past 6 months\n\n          -  Is taking medications for urinary incontinence other than anticholinergics\n\n          -  History of kidney stones\n\n          -  Has a prosthetic heart valve\n\n          -  Unable to tolerate any form of antibiotic\n\n          -  Taking anticoagulation therapy, other than aspirin\n\n          -  Has urinary incontinence due to Intrinsic Sphincter Deficiency (ISD)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01676662", 
            "org_study_id": "CD 1004"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Treatment on Day 0", 
                    "Sham Treatment on Day 0"
                ], 
                "description": "Subjects may undergo treatment every 12 months until study completion.", 
                "intervention_name": "Solace Bladder Control System", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sham Treatment on Day 0", 
                "description": "Sham procedure that resembles treatment with the Solace Bladder Control System", 
                "intervention_name": "Solace Sham Treatment", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Urinary Incontinence", 
            "Urinary Incontinence, Stress", 
            "Urination Disorders", 
            "Urologic Diseases", 
            "Urological Manifestations", 
            "Signs and Symptoms"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Antwerp", 
                        "country": "Belgium", 
                        "state": "Edegem", 
                        "zip": "2650"
                    }, 
                    "name": "University of Antwerp Hospital (Universitair Ziekenhuis Antwerpen)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "B-1090"
                    }, 
                    "name": "UZ Brussel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium"
                    }, 
                    "name": "UZ Gent"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Naples (Napoli)", 
                        "country": "Italy", 
                        "zip": "80131"
                    }, 
                    "name": "University of Naples (Universit\u00e0 Degli Studi Di Napoli \"Federico II\" )"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy"
                    }, 
                    "name": "Universita Campus Bio-medico di Roma"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands"
                    }, 
                    "name": "Catharina Ziekenhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maastricht", 
                        "country": "Netherlands", 
                        "zip": "6229 HX"
                    }, 
                    "name": "Maastricht University Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Italy", 
                "Netherlands"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "An Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects With Stress Urinary Incontinence", 
        "other_outcome": [
            {
                "description": "Rate of incidence of all adverse events for all patients", 
                "measure": "Incidence of all adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "36 Months"
            }, 
            {
                "measure": "Improvement in quality of life in all patients assessed with pad weight tests and questionnaires", 
                "safety_issue": "No", 
                "time_frame": "36 Months"
            }, 
            {
                "description": "Severity of all adverse events for all patients", 
                "measure": "Severity of all adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "36 Months"
            }
        ], 
        "overall_official": {
            "affiliation": "University of Naples", 
            "last_name": "Giovanni Tommaselli, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "Italy: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparison of increases in pad weight test and patient reported outcomes on questionnaires.", 
            "measure": "Improvement in quality of life as assessed by pad weight tests assessments and questionnaires", 
            "safety_issue": "No", 
            "time_frame": "3 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01676662"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Site-reported adverse events designated as related to the treatment.", 
                "measure": "Incidence of treatment-related adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "3 Months"
            }, 
            {
                "description": "Site-reported adverse events designated as related to the treatment.", 
                "measure": "Severity of treatment-related adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "3 Months"
            }
        ], 
        "source": "Solace Therapeutics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Solace Therapeutics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}